Cargando…
D-dimer as a predictor of cardiovascular outcomes in patients with diabetes mellitus
OBJECTIVE: This study aimed to investigate the association between D-dimer and cardiovascular diseases outcomes in patients with type 2 diabetes. METHODS: This is a single-center retrospective cohort study which was performed in a population who had health examinations between 2010 and 2015 in Jiang...
Autores principales: | Cheng, Lan, Fu, Qianyu, Zhou, Longhua, Fan, Yuqin, Liu, Fenfen, Fan, Yuanyuan, Zhang, Xin, Lin, Weiqing, Wu, Xiaohe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895572/ https://www.ncbi.nlm.nih.gov/pubmed/35246061 http://dx.doi.org/10.1186/s12872-022-02531-x |
Ejemplares similares
-
Effect of SGLT-2 inhibitor, empagliflozin, on blood pressure reduction in Chinese elderly hypertension patients with type 2 diabetes and its possible mechanisms
por: Cheng, Lan, et al.
Publicado: (2022) -
Dapagliflozin, metformin, monotherapy or both in patients with metabolic syndrome
por: Cheng, Lan, et al.
Publicado: (2021) -
Effect of SGLT-2 inhibitor, dapagliflozin, on left ventricular remodeling in patients with type 2 diabetes and HFrEF
por: Fu, Qianyu, et al.
Publicado: (2023) -
Relation of D-dimer levels of COVID-19 patients with diabetes mellitus
por: Mishra, Yogendra, et al.
Publicado: (2020) -
Association of different biomarkers of renal function with D-dimer levels in patients with type 1 diabetes mellitus (renal biomarkers and D-dimer in diabetes)
por: Domingueti, Caroline Pereira, et al.
Publicado: (2018)